The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)
NCT06412224
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
6
Enrollment
OTHER
Sponsor class
Conditions
PDR - Proliferative Diabetic Retinopathy
Interventions
DRUG:
RRG001
Sponsor
Li Xiaorong
Collaborators
[object Object]